The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
Britain has apparently found a solution to the global unemployment crisis: Weight loss shots. Prime Minister Keir Starmer ...